Skip to content
Catalyst

Matricaria chamomillaFinding

Matricaria chamomilla decreases body mass

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“During the 26-week continuation phase, the chamomile group had a relatively lower weight than the placebo group (P = 0.046; Fig. 4).”
Quoted verbatim from Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
This finding among the 85 findings on its endpoint

Matricaria chamomilla

Body mass

lowers

Who
adults with moderate-to-severe generalized anxiety disorder who responded to 12 weeks of open-label chamomile extract, then randomized to continue chamomile or switch to placebo for 26 weeks
Dose studied
1500 mg/day dry extract (500 mg capsule three times daily)

Moderate evidencePMID 27912875 · 2016

02 · The study

Study
RCT
Duration
6 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FX2PN12E1R4GVTCRCJJFNZ